Frontiers in Cell and Developmental Biology,
Journal Year:
2021,
Volume and Issue:
9
Published: April 8, 2021
Short-chain
fatty
acids
(SCFA)
derived
from
gut
microbial
fermentation
of
fiber
have
been
shown
to
exert
anti-inflammatory
and
immune-modulatory
properties
in
acute
kidney
injury
(AKI).
However
the
direct
mechanistic
link
between
SCFAs,
diet
microbiome
is
yet
be
established.
Using
murine
model
folic-acid
nephropathy
(FAN),
we
examined
effect
dietary
on
development
AKI
(day
2)
subsequent
chronic
disease
(CKD)
28).
FAN
was
induced
wild-type
knockout
mice
lacking
G
protein–coupled
receptors
GPR41
,
GPR43
or
GPR109A
.
Mice
were
randomized
high-fiber
normal-chow
diets,
SCFAs
drinking
water.
We
used
16S
rRNA
sequencing
assess
1
H-NMR
spectroscopy
for
metabolic
profiles.
fed
partially
protected
against
CKD,
exhibiting
better
function
throughout,
less
tubular
at
day
2
interstitial
fibrosis
inflammation
28
vs
controls.
Fiber
modified
alleviated
dysbiosis
by
AKI,
promoting
expansion
SCFA-producing
bacteria
Bifidobacterium
Prevotella
which
increased
fecal
serum
SCFA
concentrations.
treatment
achieved
similar
protection,
but
not
absence
GPR109A.
Histone
deacetylase
activity
(HDAC)
inhibited
kidneys
mice.
conclude
that
manipulation
protects
mediated
HDAC
inhibition
activation
SCFAs.
This
study
highlights
potential
as
a
modifiable
target
prevention
AKI.
Nutrients,
Journal Year:
2018,
Volume and Issue:
11(1), P. 51 - 51
Published: Dec. 27, 2018
Fiber
fermentation
by
gut
microbiota
yields
short-chain
fatty
acids
(SCFAs)
that
are
either
absorbed
the
or
excreted
in
feces.
Studies
conflicting
as
to
whether
SCFAs
beneficial
detrimental
cardiometabolic
health,
and
how
associated
with
is
unclear.
In
this
study
of
441
community-dwelling
adults,
we
examined
associations
fecal
SCFAs,
diversity
composition,
permeability,
outcomes,
including
obesity
hypertension.
We
assessed
16S
rRNA
gene
sequencing,
SCFA
concentrations
gas
chromatography/mass
spectrometry.
Fecal
were
inversely
diversity,
70
unique
microbial
taxa
differentially
at
least
one
(acetate,
butyrate
propionate).
Higher
a
measure
markers
metabolic
dysregulation,
Microbial
showed
association
these
outcomes
opposite
direction.
Associations
significant
after
adjusting
for
measured
confounders.
conclusion,
higher
excretion
was
evidence
dysbiosis,
excess
adiposity,
risk
factors.
assessing
both
circulating
needed
test
hypothesis
dysregulation
due
less
efficient
absorption.
Molecular and Cellular Endocrinology,
Journal Year:
2022,
Volume and Issue:
546, P. 111572 - 111572
Published: Jan. 20, 2022
The
role
of
the
intestinal
microbiota
as
a
regulator
gut-brain
axis
signalling
has
risen
to
prominence
in
recent
years.
Understanding
relationship
between
gut
microbiota,
metabolites
it
produces,
and
brain
will
be
critical
for
subsequent
development
new
therapeutic
approaches,
including
identification
novel
psychobiotics.
A
key
focus
this
regard
have
been
short-chain
fatty
acids
(SCFAs)
produced
by
bacterial
fermentation
dietary
fibre,
which
include
butyrate,
acetate,
propionate.
Ongoing
research
is
focused
on
entry
SCFAs
into
systemic
circulation
from
lumen,
their
migration
cerebral
across
blood
barrier,
potential
exert
acute
chronic
effects
structure
function.
This
review
aims
discuss
our
current
mechanistic
understanding
direct
indirect
influence
that
function,
behaviour
physiology,
inform
future
microbiota-targeted
interventions
disorders.
Neurogastroenterology & Motility,
Journal Year:
2020,
Volume and Issue:
32(10)
Published: May 31, 2020
Abstract
Background
Butyrate
has
shown
anti‐inflammatory
and
regenerative
properties,
providing
symptomatic
relief
when
orally
supplemented
in
patients
suffering
from
various
colonic
diseases.
We
investigated
the
effect
of
a
colonic‐delivery
formulation
butyrate
on
fecal
microbiota
with
inflammatory
bowel
diseases
(IBDs).
Methods
In
this
double‐blind,
placebo‐controlled,
pilot
study,
49
IBD
(n
=
19
Crohn's
disease,
CD
n
30
ulcerative
colitis,
UC)
were
randomized
to
oral
administration
microencapsulated‐sodium‐butyrate
(BLM)
or
placebo
for
2
months,
addition
conventional
therapy.
Eighteen
healthy
volunteers
(HVs)
recruited
provide
model
local
people.
Fecal
stool
samples
was
assessed
by
16S
sequencing.
Clinical
disease
activity
quality
life
(QoL)
evaluated
before
after
treatment.
Key
Results
At
baseline,
HVs
showed
different
composition
compared
patients.
Sodium‐butyrate
altered
gut
increasing
bacteria
able
produce
SCFA
UC
(
Lachnospiraceae
spp.)
butyrogenic
Butyricicoccus
).
patients,
QoL
positively
affected
Conclusions
Inferences
supplementation
increases
growth
potentially
action.
The
clinical
impact
finding
requires
further
investigation.
Aging and Disease,
Journal Year:
2022,
Volume and Issue:
13(4), P. 1252 - 1252
Published: Jan. 1, 2022
Short-chain
fatty
acids
(SCFAs)
are
important
metabolites
derived
from
the
gut
microbiota
through
fermentation
of
dietary
fiber.
SCFAs
participate
a
number
physiological
and
pathological
processes
in
human
body,
such
as
host
metabolism,
immune
regulation,
appetite
regulation.
Recent
studies
on
gut-brain
interaction
have
shown
that
mediators
interactions
involved
occurrence
development
many
neurodegenerative
diseases,
including
Alzheimer's
disease.
This
review
summarizes
current
research
potential
roles
mechanisms
AD.
First,
we
introduce
metabolic
distribution,
specific
receptors
signaling
pathways
body.
The
concentration
levels
AD
patient/animal
models
then
summarized.
In
addition,
illustrate
effects
cognitive
level,
features
(Aβ
tau)
neuroinflammation
Finally,
analyze
translational
value
therapeutic
targets
for
treatment
Frontiers in Microbiology,
Journal Year:
2023,
Volume and Issue:
14
Published: Jan. 17, 2023
The
concept
of
the
gut
microbiome
is
emerging
as
a
metabolic
interactome
influenced
by
diet,
xenobiotics,
genetics,
and
other
environmental
factors
that
affect
host’s
absorption
nutrients,
metabolism,
immune
system.
Beyond
nutrient
digestion
production,
also
functions
personalized
polypharmacy,
where
bioactive
metabolites
our
microbes
excrete
or
conjugate
may
reach
systemic
circulation
impact
all
organs,
including
brain.
Appreciable
evidence
shows
microbiota
produce
diverse
neuroactive
metabolites,
particularly
neurotransmitters
(and
their
precursors),
stimulating
local
nervous
system
(i.e.,
enteric
vagus
nerves)
affecting
brain
function
cognition.
Several
studies
have
demonstrated
correlations
between
central
sparking
an
exciting
new
research
field,
neuromicrobiology.
Microbiome-targeted
interventions
are
seen
promising
adjunctive
treatments
(pre-,
pro-,
post-,
synbiotics),
but
mechanisms
underlying
host-microbiome
interactions
yet
to
be
established,
thus
preventing
informed
evidence-based
therapeutic
applications.
In
this
paper,
we
review
current
state
knowledge
for
each
major
classes
microbial
emphasizing
biological
effects
on
microbiome,
environment,
Also,
discuss
biosynthesis,
absorption,
transport
microbiota-derived
implication
in
mental
disorders.
Animals,
Journal Year:
2022,
Volume and Issue:
12(15), P. 1981 - 1981
Published: Aug. 4, 2022
The
importance
of
dietary
supplementation
animal
feeds
with
trace
minerals
is
irrefutable,
various
forms
both
organic
and
inorganic
products
commercially
available.
With
advances
in
research
techniques,
data
obtained
from
in-vitro
in-vivo
studies
recent
years,
differences
between
have
become
more
apparent.
Furthermore,
specific
mineral
types
can
now
be
identified.
Adhering
to
PRISMA
guidelines
for
systematic
reviews,
we
carried
out
an
extensive
literature
search
on
previously
published
detailing
performance
responses
minerals,
addition
their
corresponding
relative
bioavailability
values.
This
review
covers
four
the
main
included
feed:
copper,
iron,
manganese
zinc,
encompasses
different
Their
impact
environmental,
economic,
nutritional
perspectives
are
discussed,
along
biological
availability
production
animals.
Species-specific
sections
cover
ruminants,
poultry,
swine.
Extensive
tables
values
all
available,
including
those
not
reviewed
earlier
studies,
thereby
providing
a
comprehensive
industry
reference
guide.
Additionally,
examine
reasons
variance
reported
values,
emphasis
accounting
misinterpretation.
AJP Heart and Circulatory Physiology,
Journal Year:
2019,
Volume and Issue:
317(5), P. H923 - H938
Published: Aug. 30, 2019
Cardiovascular
disease
(CVD)
is
the
leading
cause
of
death
worldwide.
The
human
body
populated
by
a
diverse
community
microbes,
dominated
bacteria,
but
also
including
viruses
and
fungi.
largest
most
complex
these
communities
located
in
gastrointestinal
system
and,
with
its
associated
genome,
known
as
gut
microbiome.
Gut
microbiome
perturbations
related
dysbiosis
have
been
implicated
progression
pathogenesis
CVD,
atherosclerosis,
hypertension,
heart
failure.
Although
there
advances
characterization
analysis
microbiota
bacterial
metabolites,
exact
mechanisms
through
which
they
exert
their
action
are
not
well
understood.
This
review
will
focus
on
role
functional
components
development
atherosclerosis.
Potential
treatments
to
alter
prevent
or
treat
atherosclerosis
CVD
discussed.